Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Jeffry Evans · SciRah

Researcher profile · Semantic Scholar

T. Jeffry Evans

Share profile

T. Jeffry Evans — researcher profile on SciRah

h-index: 18
Works: 60
Citations: 1,106

Most-cited papers

Capecitabine (Xeloda) in combination with oxaliplatin: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors.
E. Díaz-Rubio, T. Jeffry Evans, J. Tabernero, J. Cassidy +5 more
2002Annals of Oncology119 citations Open access
Semantic Scholar
Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma.
D. I. Jodrell, T. Jeffry Evans, W. Steward, David Cameron +9 more
2004European Journal of Cancer111 citations
Semantic Scholar
Developing histone deacetylase inhibitors as anti-cancer therapeutics.
B. Venugopal, T. Jeffry Evans
2011Current Medicinal Chemistry89 citations
Semantic Scholar
Protracted oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant disease.
M. Seymour, J. Mansi, C. Gallagher, M. Gore +4 more
1994British Journal of Cancer76 citations Open access
Semantic Scholar
A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma
L. Scott, Jc Yao, Al B. Benson, A. L. Thomas +7 more
2008Cancer Chemotherapy and Pharmacology70 citations
Semantic Scholar
A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer.
T. Jeffry Evans, F. Lofts, J. Mansi, J. Glees +2 more
1996British Journal of Cancer65 citations Open access
Semantic Scholar
Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma.
T. Jeffry Evans, M. Rowlands, M. Law, R. Coombes
1994British Journal of Cancer60 citations Open access
Semantic Scholar
Pharmacokinetic and pharmacodynamic properties of an oral formulation of the histone deacetylase inhibitor Belinostat (PXD101)
N. Steele, J. Plumb, L. Vidal, J. Tjørnelund +6 more
2011Cancer Chemotherapy and Pharmacology53 citations
Semantic Scholar
A double-blind study of the efficacy of metronidazole gel in the treatment of malodorous fungating tumours.
M. Bower, R. C. Stein, T. Jeffry Evans, A. Hedley +2 more
1992European Journal of Cancer51 citations
Semantic Scholar
A randomised study to determine whether routine intravenous magnesium supplements are necessary in patients receiving cisplatin chemotherapy with continuous infusion 5-fluorouracil.
T. Jeffry Evans, C. Harper, I. Beveridge, R. Wastnage +1 more
1995European Journal of Cancer44 citations
Semantic Scholar
Clinical imaging of cancer metastasis.
R. Glasspool, T. Jeffry Evans
2000European Journal of Cancer37 citations
Semantic Scholar
Inflammatory demyelinating polyneuropathy: a complication of immunotherapy in malignant melanoma.
D. Anthoney, I. Bone, T. Jeffry Evans
2000Annals of Oncology34 citations Open access
Semantic Scholar
Phase I dose-escalation study of the SRC and multi-kinase inhibitor BMS-354825 in patients (pts) with GIST and other solid tumors
T. Jeffry Evans, J. Morgan, A. D. Van den Abbeele, I. McPherson +6 more
200528 citations
Semantic Scholar
Phase I dose-escalation study of continuous oral dosing of OSI-906, a dual tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR), in patients with advanced solid tumors.
T. Jeffry Evans, C. Lindsay, E. Chan, B. Tait +6 more
201020 citations
Semantic Scholar
Bile duct stents: is there an increased rate of complications in patients receiving chemotherapy?
F. Lofts, T. Jeffry Evans, J. Mansi, J. Glees +1 more
1997European Journal of Cancer20 citations
Semantic Scholar
Response of metastatic anal carcinoma to single agent carboplatin.
T. Jeffry Evans, J. Mansi, J. Glees
1993Clinics in oncology20 citations
Semantic Scholar
A phase I and pharmacokinetic study of elisidepsin (PM02734) in patients with advanced solid tumors
R. Salazar, R. Jones, A. Oaknin, D. Crawford +8 more
2012Cancer Chemotherapy and Pharmacology19 citations
Semantic Scholar
Phase I dose escalation study of continuous oral dosing of OSI-906, an insulin like growth factor-1 receptor (IGF-1R) tyrosine kinase inhibitor, in patients with advanced solid tumors.
Colin R Lindsay, E. Chan, T. Jeffry Evans, S. Campbell +6 more
2016Journal of Clinical Oncology18 citations
Semantic Scholar
Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours
T. Jeffry Evans, E. Dean, L. Molife, Juanita Lopez +10 more
2019British Journal of Cancer16 citations Open access
Semantic Scholar
A first-in-human phase I and pharmacokinetic study of CP-4126 (CO-101), a nucleoside analogue, in patients with advanced solid tumours
B. Venugopal, A. Awada, T. Jeffry Evans, S. Dueland +5 more
2015Cancer Chemotherapy and Pharmacology16 citations
Semantic Scholar
A phase I study of E7080 in patients (pts) with advanced malignancies
H. Glen, D. Boß, R. Morrison, M. Roelvink +6 more
200813 citations
Semantic Scholar
Primary non-Hodgkin's lymphoma of the thyroid with bone marrow infiltration at presentation.
T. Jeffry Evans, J. Mansi, D. Bevan, A. Dalgleish +1 more
1995Clinics in oncology13 citations
Semantic Scholar
A phase 1 study of OSI-930 in combination with erlotinib in patients with advanced solid tumours.
I. Macpherson, S. Poondru, G. Simon, Richard Gedrich +5 more
2013European Journal of Cancer12 citations
Semantic Scholar
A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract
J. Graham, K. Boyd, F. Coxon, L. Wall +7 more
2016BMC Research Notes10 citations Open access
Semantic Scholar
Phase I evaluation of the effects of ketoconazole and rifampicin on cediranib pharmacokinetics in patients with solid tumours
U. Lassen, Wilson H. Miller, S. Hotte, T. Jeffry Evans +9 more
2013Cancer Chemotherapy and Pharmacology10 citations
Semantic Scholar
Raltitrexed (Tomudex) in combination with platinum-based agents and/or anthracyclines: preliminary results of phase I clinical trials.
J. Armand, L. Seymour, T. Jeffry Evans
1999European Journal of Cancer10 citations
Semantic Scholar
Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses
D. Anthoney, J. Naik, I. Macpherson, D. Crawford +8 more
2012BMC Cancer9 citations Open access
Semantic Scholar
Outpatient treatment with epirubicin and oral etoposide in patients with small-cell lung cancer.
H. Gogas, F. Lofts, T. Jeffry Evans, F. Millard +2 more
1997British Journal of Cancer8 citations Open access
Semantic Scholar
A phase I dose finding study of E7080 in patients (pts) with advanced malignancies
H. Glen, D. Boss, T. Jeffry Evans, M. Roelvink +6 more
20077 citations
Semantic Scholar
A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine
C. Twelves, A. Anthoney, C. Savulsky, M. Guo +8 more
2019British Journal of Cancer6 citations Open access
Semantic Scholar
Clinical applications of new aromatase inhibitors.
T. Jeffry Evans
1994Critical reviews in oncology/hematology6 citations
Semantic Scholar
383 POSTER A Phase I Study of dasatinib, a Src and multi-kinase inhibitor, in patients (pts) with GIST and other solid tumors
J. Morgan, G. Demetri, D. Wang, I. Macpherson +6 more
20065 citations
Semantic Scholar
Magnesium supplements with cisplatin chemotherapy.
F. Lofts, T. Jeffry Evans, R. Wastnage, J. Mansi
1996European Journal of Cancer5 citations
Semantic Scholar
Mechanisms in removal of tumor by antibody
G. Stevenson, A. Bell, T. Jeffry Evans, R. French +4 more
2007Cell Biophysics4 citations
Semantic Scholar
Assessment of clinical activity of E7080, a multitargeted kinase inhibitor, in patients with advanced melanoma treated in two phase I trials.
D. Hong, D. Boss, H. Glen, J. Mink +7 more
2011Journal of Clinical Oncology3 citations
Semantic Scholar
58 Pharmacodynamic responses to a novel histone deacetylase inhibitor, PXD101, in mice and humans
J. Plumb, N. Steele, T. Jeffry Evans, P. Finn +4 more
20043 citations
Semantic Scholar
Should we be using 5-HT3 antagonists as first line antiemetic therapy in cisplatin-based chemotherapy?
J. Mansi, T. Jeffry Evans, A. Smith, C. Oakley +2 more
1993Annals of Oncology3 citations Open access
Semantic Scholar
1211TiPFAK-PD1: a phase I/IIa trial of FAK (defactinib) & PD-1 (pembrolizumab) inhibition
S. Symeonides, T. Jeffry Evans, V. Coyle, A. Serrels +6 more
20172 citations Open access
Semantic Scholar
Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma
D. Propper, Keith Jones, D. Anthoney, W. Mansoor +7 more
2016BMC Cancer2 citations Open access
Semantic Scholar
Final results of a phase 1 and PK study of capecitabine (XEL) in combination with epirubicin (E) and cisplatin (C) [ECC] in patients with advanced oesophagogastric (OG) adenocarcinoma
T. Jeffry Evans, J. Paul, A. McInnes, N. Raby +3 more
20012 citations
Semantic Scholar
Phase 1 multicenter, open-label study to establish the maximum tolerated dose (MTD) of two administration schedules of E7389 (eribulin) liposomal formulation in patients (pts) with solid tumors
Ishtiaq Zubairi, E. Dean, L. Molife, Juanita Lopez +12 more
20161 citations
Semantic Scholar
1139PDCLINICAL OUTCOMES FROM THE UK CUP-ONE STUDY: A MULTI-CENTRE TRIAL TO ASSESS THE EFFICACY OF EPIRUBICIN, CISPLATIN AND CAPECITABINE (ECX) IN CARCINOMAS OF UNKNOWN PRIMARY (CUP) WITH PROSPECTIVE VALIDATION OF MOLECULAR CLASSIFIERS.
H. Wasan, James Paul, M. Nicolson, T. Jeffry Evans +7 more
2014Annals of Oncology1 citations Open access
Semantic Scholar
467PFGFR INHIBITOR AND CHEMOTHERAPY IN GASTRIC CANCER (FACING): PHASE I RESULTS FROM AN ECMC COMBINATIONS ALLIANCE PHASE I/II TRIAL OF AZD4547 IN COMBINATION WITH CISPLATIN AND CAPECITABINE (CX).
C. Lindsay, F. Thistlethwaite, Avinash Gupta, W. Mansoor +13 more
2014Annals of Oncology1 citations Open access
Semantic Scholar
Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses
D. Anthoney, J. Naik, I. Macpherson, D. Crawford +8 more
2012BMC Cancer1 citations Open access
Semantic Scholar
A first-in-human phase I study of JNJ-26481585, a novel oral histone deacetylase inhibitor (HDACi), in patients with advanced cancer with evidence of target modulation and antitumor activity.
Richard D. Baird, B. Venugopal, R. Kristeleit, J. Charlton +16 more
2011Journal of Clinical Oncology1 citations
Semantic Scholar
6590 POSTER Phase Ma Study of TP300 as 1st-line Monotherapy in Patients With Advanced Gastric (GC) or Gastro-oesophageal Junction (GOJ) Carcinoma
T. Jeffry Evans, D. Propper, D. Anthoney, W. Mansoor +5 more
20111 citations
Semantic Scholar
The use of routine magnesium supplements with a cisplatin-containing chemotherapy regimen
T. Jeffry Evans, C. Harper, I. Beveridge, R. Wasinage +2 more
19931 citations
Semantic Scholar
A dose escalation (DE), pharmacokinetic (PK), and pharmacodynamic (PD) study of OSI-930 and erlotinib (E) in patients (pts) with advanced solid tumors.
I. Macpherson, K. Stewart, J. Chick, K. Brock +4 more
2016Journal of Clinical Oncology0 citations
Semantic Scholar
Gemcitabine elaidate cytotoxic agent oncolytic
B. Venugopal, T. Jeffry Evans
20110 citations
Semantic Scholar
IMAGE, a randomized phase Ib/II study of elisidepsin in pretreated advanced gastroesophageal cancer.
S. Szyldergemajn, A. Gonçalves, J. Metges, K. Gunzer +8 more
2011Journal of Clinical Oncology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Mansi×10
Invite
J. Mansi — researcher profile on SciRah
D. Anthoney×5
Invite
D. Anthoney — researcher profile on SciRah
D. Crawford×5
Invite
D. Crawford — researcher profile on SciRah
I. Macpherson×5
Invite
I. Macpherson — researcher profile on SciRah

×4

Invite

M. Eatock — researcher profile on SciRah

B. Venugopal×4

Invite

B. Venugopal — researcher profile on SciRah

Invite

F. Lofts — researcher profile on SciRah

Invite

A. Stephens — researcher profile on SciRah

Invite

S. Poondru — researcher profile on SciRah

Invite

R. Morrison — researcher profile on SciRah

Invite

R. Wastnage — researcher profile on SciRah

Invite

C. Hopkins — researcher profile on SciRah